Global Nuclear Receptor ROR-Gamma Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Nuclear Receptor ROR-Gamma Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Nuclear Receptor ROR-Gamma Market Overview:
Global Nuclear Receptor ROR-Gamma Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Nuclear Receptor ROR-Gamma involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Nuclear Receptor ROR-Gamma Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Nuclear Receptor ROR-Gamma market in 2020.
Global Nuclear Receptor ROR-Gamma Market Segmentation
By Type, Nuclear Receptor ROR-Gamma market has been segmented into:
VPR-66
INV-17
GSK-2981278
BBI-6000
Others
By Application, Nuclear Receptor ROR-Gamma market has been segmented into:
Hospital
Clinic
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Nuclear Receptor ROR-Gamma market are:
4SC AG
Advinus Therapeutics Ltd.
Arrien Pharmaceuticals LLC
Aurigene Discovery Technologies Limited
Biogen Inc.
Brickell Biotech Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals
Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals Inc.
Vitae Pharmaceuticals Inc.
1. Market Overview of Nuclear Receptor ROR-Gamma
1.1 Nuclear Receptor ROR-Gamma Market Overview
1.1.1 Nuclear Receptor ROR-Gamma Product Scope
1.1.2 Market Status and Outlook
1.2 Nuclear Receptor ROR-Gamma Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Nuclear Receptor ROR-Gamma Historic Market Size by Regions (2015-2020)
1.4 Nuclear Receptor ROR-Gamma Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Nuclear Receptor ROR-Gamma Sales Market by Type (2015-2026)
2.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Type (2015-2020)
2.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2021-2026)
2.3 VPR-66
2.4 INV-17
2.5 GSK-2981278
2.6 BBI-6000
2.7 Others
3. Covid-19 Impact Nuclear Receptor ROR-Gamma Sales Market by Application (2015-2026)
3.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Application (2015-2020)
3.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2021-2026)
3.3 Hospital
3.4 Clinic
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Nuclear Receptor ROR-Gamma Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Nuclear Receptor ROR-Gamma Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Nuclear Receptor ROR-Gamma Business
5.1 4SC AG
5.1.1 4SC AG Company Profile
5.1.2 4SC AG Nuclear Receptor ROR-Gamma Product Specification
5.1.3 4SC AG Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Advinus Therapeutics Ltd.
5.2.1 Advinus Therapeutics Ltd. Company Profile
5.2.2 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Specification
5.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Arrien Pharmaceuticals LLC
5.3.1 Arrien Pharmaceuticals LLC Company Profile
5.3.2 Arrien Pharmaceuticals LLC Nuclear Receptor ROR-Gamma Product Specification
5.3.3 Arrien Pharmaceuticals LLC Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Aurigene Discovery Technologies Limited
5.4.1 Aurigene Discovery Technologies Limited Company Profile
5.4.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Specification
5.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Biogen Inc.
5.5.1 Biogen Inc. Company Profile
5.5.2 Biogen Inc. Nuclear Receptor ROR-Gamma Product Specification
5.5.3 Biogen Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Brickell Biotech Inc.
5.6.1 Brickell Biotech Inc. Company Profile
5.6.2 Brickell Biotech Inc. Nuclear Receptor ROR-Gamma Product Specification
5.6.3 Brickell Biotech Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Bristol-Myers Squibb Company
5.7.1 Bristol-Myers Squibb Company Company Profile
5.7.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Specification
5.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Celgene Corporation
5.8.1 Celgene Corporation Company Profile
5.8.2 Celgene Corporation Nuclear Receptor ROR-Gamma Product Specification
5.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Genentech Inc.
5.9.1 Genentech Inc. Company Profile
5.9.2 Genentech Inc. Nuclear Receptor ROR-Gamma Product Specification
5.9.3 Genentech Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Genfit SA
5.10.1 Genfit SA Company Profile
5.10.2 Genfit SA Nuclear Receptor ROR-Gamma Product Specification
5.10.3 Genfit SA Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 GlaxoSmithKline Plc
5.11.1 GlaxoSmithKline Plc Company Profile
5.11.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Specification
5.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Hanmi Pharmaceuticals
5.12.1 Hanmi Pharmaceuticals Company Profile
5.12.2 Hanmi Pharmaceuticals Nuclear Receptor ROR-Gamma Product Specification
5.12.3 Hanmi Pharmaceuticals Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Co. Ltd.
5.13.1 Co. Ltd. Company Profile
5.13.2 Co. Ltd. Nuclear Receptor ROR-Gamma Product Specification
5.13.3 Co. Ltd. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Karo Bio AB
5.14.1 Karo Bio AB Company Profile
5.14.2 Karo Bio AB Nuclear Receptor ROR-Gamma Product Specification
5.14.3 Karo Bio AB Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Lead Pharma Holding B.V.
5.15.1 Lead Pharma Holding B.V. Company Profile
5.15.2 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Specification
5.15.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Nuevolution AB
5.16.1 Nuevolution AB Company Profile
5.16.2 Nuevolution AB Nuclear Receptor ROR-Gamma Product Specification
5.16.3 Nuevolution AB Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Phenex Pharmaceuticals AG
5.17.1 Phenex Pharmaceuticals AG Company Profile
5.17.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Specification
5.17.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Reata Pharmaceuticals Inc.
5.18.1 Reata Pharmaceuticals Inc. Company Profile
5.18.2 Reata Pharmaceuticals Inc. Nuclear Receptor ROR-Gamma Product Specification
5.18.3 Reata Pharmaceuticals Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Teijin Pharma Limited
5.19.1 Teijin Pharma Limited Company Profile
5.19.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Specification
5.19.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Visionary Pharmaceuticals Inc.
5.20.1 Visionary Pharmaceuticals Inc. Company Profile
5.20.2 Visionary Pharmaceuticals Inc. Nuclear Receptor ROR-Gamma Product Specification
5.20.3 Visionary Pharmaceuticals Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Vitae Pharmaceuticals Inc.
5.21.1 Vitae Pharmaceuticals Inc. Company Profile
5.21.2 Vitae Pharmaceuticals Inc. Nuclear Receptor ROR-Gamma Product Specification
5.21.3 Vitae Pharmaceuticals Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Nuclear Receptor ROR-Gamma Market Size (2015-2026)
6.2 North America Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
6.3 North America Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
6.4 North America Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Nuclear Receptor ROR-Gamma Market Size (2015-2026)
7.2 East Asia Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
7.3 East Asia Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
7.4 East Asia Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
8. Europe
8.1 Europe Nuclear Receptor ROR-Gamma Market Size (2015-2026)
8.2 Europe Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
8.3 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
8.4 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Nuclear Receptor ROR-Gamma Market Size (2015-2026)
9.2 South Asia Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
9.3 South Asia Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
9.4 South Asia Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Nuclear Receptor ROR-Gamma Market Size (2015-2026)
10.2 Southeast Asia Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
10.3 Southeast Asia Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
10.4 Southeast Asia Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Nuclear Receptor ROR-Gamma Market Size (2015-2026)
11.2 Middle East Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
11.3 Middle East Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
11.4 Middle East Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
12. Africa
12.1 Africa Nuclear Receptor ROR-Gamma Market Size (2015-2026)
12.2 Africa Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
12.3 Africa Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
12.4 Africa Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Nuclear Receptor ROR-Gamma Market Size (2015-2026)
13.2 Oceania Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
13.3 Oceania Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
13.4 Oceania Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
14. South America
14.1 South America Nuclear Receptor ROR-Gamma Market Size (2015-2026)
14.2 South America Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
14.3 South America Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
14.4 South America Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Nuclear Receptor ROR-Gamma Market Size (2015-2026)
15.2 Rest of the World Nuclear Receptor ROR-Gamma Key Players in North America (2015-2020)
15.3 Rest of the World Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
15.4 Rest of the World Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
16 Nuclear Receptor ROR-Gamma Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Nuclear Receptor ROR Gamma Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|